VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAD

Journal of Experimental Medicine

Volumn 209, Issue 7, 2012, Pages 1363-1377

  Sun, Zuyue ^a   Li, Xiujuan ^a   Massena, Sara ^b   Kutschera, Simone ^a   Padhan, Narendra ^a   Gualandi, Laura ^a   Sundvold Gjerstad, Vibeke ^d   Gustafsson, Karin ^b   Choy, Wing Wen ^c   Zang, Guangxiang ^b   Quach, My ^b   Jansson, Leif ^b   Phillipson, Mia ^b   Abid, Md Ruhul ^e   Spurkland, Anne ^d   Claesson Welsh, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OSLO   (Norway)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EVANS BLUE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GROWTH FACTOR; HISTAMINE; MICROSPHERE; NITRIC OXIDE; PHOSPHOLIPASE C GAMMA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT PROTEIN; SARACATINIB; T CELL SPECIFIC ADAPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LUNG; MICROVASCULATURE; MOUSE; MUSCLE BLOOD VESSEL; NANOTECHNOLOGY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; SKIN; SRC HOMOLOGY DOMAIN; T LYMPHOCYTE; TRACHEA; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROSPHERES; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84864292241     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111343     Document Type: Article

References (59)

1. Adam, A.P., A.L. Sharenko, K. Pumiglia, and P.A. Vincent. 2010. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J. Biol. Chem. 285:7045-7055. http://dx.doi.org/10.1074/jbc.M109.079277
2. Baluk, P., A. Hirata, G. Thurston, T. Fujiwara, C.R. Neal, C.C. Michel, and D.M. McDonald. 1997. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am. J. Physiol. 272:L155-L170.
3. Carlsson, P.O., A. Andersson, and L. Jansson. 1996. Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice. Am. J. Physiol. 271:E990-E995.
4. Chen, X.L., J.O. Nam, C. Jean, C. Lawson, C.T. Walsh, E. Goka, S.T. Lim, A. Tomar, I. Tancioni, S. Uryu, et al. 2012. VEGF-induced vascular permeability is mediated by FAK. Dev. Cell. 22:146-157. http://dx.doi.org/10.1016/j.devcel.2011.11.002
5. Choi, Y.B., C.K. Kim, and Y. Yun. 1999. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation. J. Immunol. 163:5242-5249.
6. Di Lorenzo, A., C. Fernández-Hernando, G. Cirino, and W.C. Sessa. 2009. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc. Natl. Acad. Sci. USA. 106:14552-14557. http://dx.doi.org/10.1073/pnas.0904073106
7. Dougher-Vermazen, M., J.D. Hulmes, P. Böhlen, and B.I. Terman. 1994. Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem. Biophys. Res. Commun. 205:728-738. http://dx.doi.org/10.1006/bbrc .1994.2726
8. Drappa, J., L.A. Kamen, E. Chan, M. Georgiev, D. Ashany, F. Marti, and P.D. King. 2003. Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J. Exp. Med. 198:809-821. http://dx.doi.org/10.1084/jem.20021358
9. Durán, W.N., J.W. Breslin, and F.A. Sánchez. 2010. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc. Res. 87:254-261. http://dx.doi.org/10.1093/cvr/cvq139
10. Dvorak, A.M., and D. Feng. 2001. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J. Histochem. Cytochem. 49:419-432. http://dx.doi.org/10.1177/002215540104900401
11. Dvorak, H.F., J.A. Nagy, D. Feng, L.F. Brown, and A.M. Dvorak. 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237:97-132. http://dx.doi.org/10.1007/978-3-642-59953-8_6
12. Eliceiri, B.P., R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh. 1999. Selective requirement for Src kinases during VEGFinduced angiogenesis and vascular permeability. Mol. Cell. 4:915-924. http://dx.doi.org/10.1016/S1097-2765(00)80221-X
13. Esser, S., M.G. Lampugnani, M. Corada, E. Dejana, and W. Risau. 1998. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111:1853-1865.
14. Feng, D., J.A. Nagy, H.F. Dvorak, and A.M. Dvorak. 2002. Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc. Res. Tech. 57:289-326. http://dx.doi.org/10.1002/jemt.10087
15. Feng, J., S.M. Damrauer, M. Lee, F.W. Sellke, C. Ferran, and M.R. Abid. 2010. Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 30:1703-1710. http://dx.doi.org/10.1161/ATVBAHA.110.209726
16. Flynn D.C., T.H. Leu, A.B. Reynolds, and J.T. Parsons. 1993. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol. Cell. Biol.. 13:7892-7900.
17. Frank, R. 2002. High-density synthetic peptide microarrays: emerging tools for functional genomics and proteomics. Comb. Chem. High Throughput Screen. 5:429-440.
18. Fukumura, D., T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.O. Yun, D.G. Buerk, P.L. Huang, and R.K. Jain. 2001. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA. 98:2604-2609. http://dx.doi.org/10.1073/pnas.041359198
19. Fulton, D., J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A. Papapetropoulos, and W.C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:597-601. http://dx.doi.org/10.1038/21218
20. Gavard, J., and J.S. Gutkind. 2006. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8:1223-1234. http://dx.doi.org/10.1038/ncb1486
21. Granum, S., V. Sundvold-Gjerstad, K.Z. Dai, K.M. Kolltveit, K. Hildebrand, H.S. Huitfeldt, T. Lea, and A. Spurkland. 2006. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7. BMC Immunol. 7:15. http://dx.doi.org/10.1186/1471-2172-7-15
22. Granum, S., T.C. Andersen, M. Sørlie, M. Jørgensen, L. Koll, T. Berge, T. Lea, B. Fleckenstein, A. Spurkland, and V. Sundvold-Gjerstad. 2008. Modulation of Lck function through multisite docking to T cellspecific adapter protein. J. Biol. Chem. 283:21909-21919. http://dx.doi .org/10.1074/jbc.M800871200
23. Holmqvist, K., M.J. Cross, C. Rolny, R. Hägerkvist, N. Rahimi, T. Matsumoto, L. Claesson-Welsh, and M. Welsh. 2004. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J. Biol. Chem. 279:22267-22275. http://dx.doi.org/10.1074/jbc .M312729200
24. Jansson, L., and C. Hellerström. 1981. A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using nonradioactive microspheres. Acta Physiol. Scand. 113:371-374. http://dx.doi .org/10.1111/j.1748-1716.1981.tb06909.x
25. Koch, S., S. Tugues, X. Li, L. Gualandi, and L. Claesson-Welsh. 2011. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437:169-183. http://dx.doi.org/10.1042/BJ20110301
26. Kramer A., U. Reineke, L. Dong, B. Hoffmann, U. Hoffmüller, D. Winkler, R. Volkmer-Engert, and J. Schneider-Mergener. 1999. Spot synthesis: observations and optimization. J. Pept. Res. 54:319-327.
27. Lambeng, N., Y. Wallez, C. Rampon, F. Cand, G. Christé, D. Gulino-Debrac, I. Vilgrain, and P. Huber. 2005. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ. Res. 96:384-391. http://dx.doi.org/10.1161/01.RES.0000156652.99586.9f
28. Laramée, M., C. Chabot, M. Cloutier, R. Stenne, M. Holgado-Madruga, A.J. Wong, and I. Royal. 2007. The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. J. Biol. Chem. 282:7758-7769. http://dx.doi.org/10.1074/jbc.M611327200
29. Lin, M.I., J. Yu, T. Murata, and W.C. Sessa. 2007. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 67:2849-2856. http://dx.doi.org/10.1158/0008-5472.CAN-06-4082
30. Lu, Y., Y. Xiong, Y. Huo, J. Han, X. Yang, R. Zhang, D.S. Zhu, S. Klein-Hessling, J. Li, X. Zhang, et al. 2011. Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway. Proc. Natl. Acad. Sci. USA. 108:2957-2962. http://dx.doi.org/10.1073/pnas.1009395108
31. Matsumoto, T., S. Bohman, J. Dixelius, T. Berge, A. Dimberg, P. Magnusson, L. Wang, C. Wikner, J.H. Qi, C. Wernstedt, et al. 2005. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 24:2342-2353. http://dx.doi.org/10.1038/sj.emboj.7600709
32. Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86:279-367. http://dx.doi.org/10.1152/physrev.00012.2005
33. Meyer, R.D., C. Latz, and N. Rahimi. 2003. Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J. Biol. Chem. 278:16347-16355. http://dx.doi.org/10.1074/jbc. M300259200
34. Meyer, R.D., D.B. Sacks, and N. Rahimi. 2008. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS ONE. 3:e3848. http://dx.doi.org/10.1371/journal.pone.0003848
35. Nagy, J.A., L. Benjamin, H. Zeng, A.M. Dvorak, and H.F. Dvorak. 2008. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 11:109-119. http://dx.doi.org/10.1007/s10456-008-9099-z
36. Rajagopal, K., C.L. Sommers, D.C. Decker, E.O. Mitchell, U. Korthauer, A.I. Sperling, C.A. Kozak, P.E. Love, and J.A. Bluestone. 1999. RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. J. Exp. Med. 190:1657-1668. http://dx.doi .org/10.1084/jem.190.11.1657
37. Roskoski, R. Jr. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331:1-14. http://dx.doi .org/10.1016/j.bbrc.2005.03.012
38. Ruan, G.X., and A. Kazlauskas. 2012. Axl is essential for VEGF-A-dependent activation of PI3K/Akt. EMBO J. 31:1692-1703. http://dx.doi .org/10.1038/emboj.2012.21
39. Sakurai, Y., K. Ohgimoto, Y. Kataoka, N. Yoshida, and M. Shibuya. 2005. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. USA. 102:1076-1081. http://dx.doi.org/10.1073/pnas.0404984102
40. Scheppke, L., E. Aguilar, R.F. Gariano, R. Jacobson, J. Hood, J. Doukas, J. Cao, G. Noronha, S. Yee, S. Weis, et al. 2008. Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J. Clin. Invest. 118:2337-2346.
41. Senger, D.R., S.J. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:983-985. http://dx.doi.org/10.1126/science.6823562
42. Sessa, W.C. 2009. Molecular control of blood flow and angiogenesis: role of nitric oxide. J. Thromb. Haemost. 7(Suppl 1):35-37. http://dx.doi.org/10.1111/j.1538-7836.2009.03424.x
43. Solowiej, J., S. Bergqvist, M.A. McTigue, T. Marrone, T. Quenzer, M. Cobbs, K. Ryan, R.S. Kania, W. Diehl, and B.W. Murray. 2009. Characterizing the effects of the juxtamembrane domain on vascular endothelial growth factor receptor-2 enzymatic activity, autophosphorylation, and inhibition by axitinib. Biochemistry. 48:7019-7031. http://dx.doi.org/10.1021/bi900522y
44. Spurkland, A., J.E. Brinchmann, G. Markussen, F. Pedeutour, E. Munthe, T. Lea, F. Vartdal, and H.C. Aasheim. 1998. Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J. Biol. Chem. 273:4539-4546. http://dx.doi.org/10.1074/jbc.273.8.4539
45. Stohrer, M., Y. Boucher, M. Stangassinger, and R.K. Jain. 2000. Oncotic pressure in solid tumors is elevated. Cancer Res. 60:4251-4255.
46. Sundvold-Gjerstad, V., S. Granum, T. Mustelin, T.C. Andersen, T. Berge, M.J. Shapiro, V.S. Shapiro, A. Spurkland, and T. Lea. 2005. The C terminus of T cell-specific adapter protein (TSAd) is necessary for TSAd-mediated inhibition of Lck activity. Eur. J. Immunol. 35:1612-1620. http://dx.doi .org/10.1002/eji.200425638
47. Sundvold-Gjerstad, V., S. Granum, T. Berge, T.B.C. Andersen, K.M. Kolltveit, and A. Spurkland. 2007. T cell specific adapter protein in cell signalling and autoimmunity. In Lymphocyte Activation and Signal Transduction. Noah Isakov, ed. Transworld Research Network. Pages 211-220.
48. Takahashi, T., S. Yamaguchi, K. Chida, and M. Shibuya. 2001. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-Adependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20:2768-2778. http://dx.doi.org/10 .1093/emboj/20.11.2768
49. Tzima, E., M. Irani-Tehrani, W.B. Kiosses, E. Dejana, D.A. Schultz, B. Engelhardt, G. Cao, H. DeLisser, and M.A. Schwartz. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 437:426-431. http://dx.doi.org/10.1038/nature03952
50. Vandenbroucke, E., D. Mehta, R. Minshall, and A.B. Malik. 2008. Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 1123:134-145. http://dx.doi.org/10.1196/annals.1420.016
51. Vestweber, D. 2012. Novel insights into leukocyte extravasation. Curr. Opin. Hematol. 19:212-217. http://dx.doi.org/10.1097/MOH .0b013e3283523e78
52. Wallez, Y., F. Cand, F. Cruzalegui, C. Wernstedt, S. Souchelnytskyi, I. Vilgrain, and P. Huber. 2007. Src kinase phosphorylates vascular endothelialcadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene. 26:1067-1077. http://dx.doi.org/10.1038/sj.onc.1209855
53. Warner, A.J., J. Lopez-Dee, E.L. Knight, J.R. Feramisco, and S.A. Prigent. 2000. The Shc-related adaptor protein, Sck, forms a complex with the vascularendothelial-growth-factor receptor KDR in transfected cells. Biochem. J. 347:501-509. http://dx.doi.org/10.1042/0264-6021:3470501
54. Weis, S.M., and D.A. Cheresh. 2005. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 437:497-504. http://dx.doi.org/10.1038/nature03987
55. Weis, S., J. Cui, L. Barnes, and D. Cheresh. 2004a. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 167:223-229. http://dx.doi.org/10.1083/jcb.200408130
56. Weis, S., S. Shintani, A. Weber, R. Kirchmair, M. Wood, A. Cravens, H. McSharry, A. Iwakura, Y.S. Yoon, N. Himes, et al. 2004b. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J. Clin. Invest. 113:885-894.
57. Wu, L.W., L.D. Mayo, J.D. Dunbar, K.M. Kessler, O.N. Ozes, R.S. Warren, and D.B. Donner. 2000. VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. J. Biol. Chem. 275:6059-6062. http://dx.doi.org/10.1074/jbc.275.9.6059
58. Xiao, K., J. Garner, K.M. Buckley, P.A. Vincent, C.M. Chiasson, E. Dejana, V. Faundez, and A.P. Kowalczyk. 2005. p120-Catenin regulates clathrindependent endocytosis of VE-cadherin. Mol. Biol. Cell. 16:5141-5151. http://dx.doi.org/10.1091/mbc.E05-05-0440
59. Zhao, J., W. Wang, C.H. Ha, J.Y. Kim, C. Wong, E.M. Redmond, A. Hamik, M.K. Jain, G.S. Feng, and Z.G. Jin. 2011. Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis. Arterioscler. Thromb. Vasc. Biol. 31:1016-1023. http://dx.doi.org/10.1161/ATVBAHA.111.224493